CommercialCoverageHigh impact
Cardioverter-Defibrillators (CPB 0585, reviewed 2026-04-22)
Aetna·Cardiology, Cardiothoracic Surgery, Critical Care +1 more·Medical Policy
Effective date
Apr 22, 2026
We identified it
Aug 15, 2026
Summary
Aetna has updated its Cardioverter-Defibrillator policy (CPB 0585) effective April 22, 2026, establishing comprehensive medical necessity criteria for ICD implantation, extravascular/subcutaneous devices, and wearable cardioverter-defibrillators. The policy clarifies specific clinical indications, LVEF thresholds, timing requirements post-MI/revascularization, and optimal medical therapy prerequisites. Billing teams must ensure prior authorization requests include documentation of qualifying diagnoses, test results, and medical therapy duration before claiming covered CPT codes.
Action Required
By April 22, 2026: Billing and clinical teams must implement the following changes: (1) Update authorization criteria in billing software to require documentation of specific medical necessity criteria for all ICD-related procedures before claim submission; (2) For CPT 0571T (extravascular ICD insertion), 0572T (substernal electrode insertion), and 0573T (substernal electrode removal), require prior authorization with supporting documentation including LVEF results, NYHA class, post-MI/revascularization timing, and evidence of optimal medical therapy (ACE inhibitor, beta-blocker, diuretic for ≥3 months at maximum tolerated doses); (3) Create or update encounter templates and authorization forms to capture: diagnosis codes for qualifying arrhythmias, structural heart disease, inherited conditions, LVEF percentage, post-MI/revascularization dates (requiring 40-day minimum post-MI and 90-day minimum post-revascularization for ischemic cardiomyopathy indications), and medical therapy documentation; (4) Flag claims for extravascular/subcutaneous devices that do not document absence of symptomatic bradycardia, incessant VT, or prior endocarditis/infection; (5) For wearable cardioverter-defibrillators, require documentation of temporary condition (infection, pending transplant) or LVEF decline within 90 days; (6) Deny or request additional documentation for any ICD claims lacking required supporting documentation. Providers must include all qualifying diagnostic and lab documentation with authorization requests. Failure to obtain proper authorization with complete medical necessity documentation will result in claim denials.